How Proposed Cuts to Home Health Payments Could Impact Hospice M&A
Hospice News
AUGUST 29, 2022
NASDAQ: AMED), and Addus Homecare (NASDAQ: ADUS) indicated that they would prioritize home health deals this year. I would imagine we’ll have more clarity around 2023-2025 reimbursement by late this year or early next year. Buyers began regaining their appetites for home health assets as the dust began to settle around PDGM.
Let's personalize your content